World Orphan Drug Congress, WODC, Europe will be taking place in Barcelona, Spain this year.
We are delighted to share that Decisive Consulting will attend the World Orphan Drug Congress, WODC, in Barcelona in October!
Come and meet Esther Nzenza, Nic Gwatkin, and Steven Fountain at Stand 28 – we’d love to connect!
From January, 13th 2028, the Joint Clinical Assessment (JCA) becomes mandatory for orphan drugs. This will create a whole new landscape for ensuring access to medicines indicated to treat rare diseases. Join us for a conversation about upcoming anticipated challenges in the face of JCA and solutions we can co-create!
🗓️ Pre-Congress Workshops: 22 October 2024 | Catalonia Barcelona Plaza
🗓️ Main Congress: 23-25 October 2024 | Fira de Barcelona Montjuïc
Let’s collaborate to find innovative solutions to advance treatments that make a real difference in the lives of rare disease patients!